Company intelligence / Profile preview

Somru BioScience

Charlottetown, Prince Edward Island, Canadasomrubioscience.com ↗

Ownership: Private
Development stage: Commercial

Overview

Somru BioScience has developed proprietary platforms for rapid generation of high-affinity antibodies and comparability testing of biologics/biosimilars. Their reagents and kits are widely used by pharmaceutical companies to accelerate biosimilar development programs. The company also offers contract research services including immunogenicity ELISA kits and biomarker testing solutions. No direct clinical results as they do not sponsor therapeutic trials themselves.

Therapeutic areas: Other
Modalities: AntibodyBiologic
Industry: Protein Biomarker Diagnostics

Partnerships

Veeda Clinical Research (India) – joint venture partnership forming Ingenuity BioSciences bioanalytical lab in Ahmedabad

Beyond the preview

Go deeper on Somru BioScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Somru BioScience.

Explore the full profile